Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Pharma Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Nippon India | Edelweiss |
| NAV | ₹666.3420 | ₹36.4592 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 13.9 years | 8.7 years |
| Expense ratio | 1.0% | 1.4% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 75.20 | 45.20 |
Returns
| Nippon India Pharma Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| 1 month | +11.40% | +5.92% |
| 3 months | +3.74% | +2.40% |
| 6 months | +8.55% | +20.35% |
| YTD | +16.94% | +25.20% |
| 1 year | +15.26% | +23.75% |
| 3 years (CAGR) | +17.96% | +17.13% |
| 5 years (CAGR) | +15.40% | +11.04% |
| 10 years (CAGR) | +16.61% | — |
| Since launch | +17.63% | +15.95% |
Risk
| Nippon India Pharma Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Volatility | 14.1% | 20.9% |
| Downside volatility | 9.0% | 12.9% |
| Sharpe | 0.81 | 0.51 |
| Sortino | 1.28 | 0.82 |
| Calmar | 1.22 | 0.69 |
| Return / risk | 1.27 | 0.82 |
| Deepest fall | −24.02% | −32.34% |
| Days to recover | 445 | 155 |
| Below its high | +0.00% | −1.63% |
Against benchmark
| Nippon India Pharma Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Alpha | −1.86% | +5.69% |
| Beta | 0.89 | 0.97 |
| R² | 89.5% | 56.3% |
| Up capture | 85.2% | 114.2% |
| Down capture | 88.7% | 93.5% |
| Tracking error | 4.8% | 13.8% |
| Information ratio | −0.69 | 0.40 |
| Treynor | 0.12 | 0.10 |
Consistency
| Nippon India Pharma Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| Best 1-year | +90.70% | +98.01% |
| Middle 1-year | +13.13% | +17.30% |
| Worst 1-year | −15.12% | −23.25% |
| 1-year periods with a loss | 23.2% | 23.7% |
| Middle 3-year | +19.82% | +18.97% |
| Positive months | 63.9% | 66.7% |
| Best day | +3.40% | +3.68% |
| Worst day | −3.21% | −5.79% |
| Worst 5% day | −1.38% | −1.93% |
| Positive days | 53.7% | 57.6% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Nippon India Pharma Fund | Edelweiss Recently Listed IPO Fund | |
|---|---|---|
| 5-year XIRR | +18.24% | +17.87% |
| 5-year value | ₹9,54,076 | ₹9,45,521 |
| 3-year XIRR | +14.26% | +18.35% |
| 1-year XIRR | +22.08% | +35.31% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.